Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.4 GBX | 0.00% | +1.49% | -20.00% |
Apr. 30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
Apr. 15 | Fusion Antibodies inks commercial contract for OptiPhage library | AN |
Chart calendar Fusion Antibodies plc
Past events on Fusion Antibodies plc
2024-04-30 02:00 am | Q4 2024 Sales and Revenue Release - Trading Update |
2024-03-05 05:00 am | Shareholder Meeting |
2024-01-10 | Proactive One2One Virtual Investor Forum |
2023-12-07 06:00 am | Q2 2024 Earnings Call |
2023-12-04 02:00 am | Q2 2024 Earnings Release |
2023-10-26 | Annual General Meeting |
2023-10-04 06:00 am | Q4 2023 Earnings Call |
2023-09-29 02:00 am | Q4 2023 Earnings Release |
2023-06-08 05:00 am | Shareholder Meeting |
2023-03-06 02:00 am | Q4 2023 Sales and Revenue Release - Trading Update |
2022-12-09 05:00 am | Interim 2023 Earnings Call |
2022-12-05 02:00 am | Interim 2023 Earnings Release |
2022-09-22 | Annual General Meeting |
2022-09-01 06:00 am | FY 2022 Earnings Call |
2022-08-23 02:00 am | FY 2022 Earnings Release |
2022-05-06 02:00 am | FY 2022 Sales and Revenue Release - Trading Update |
2021-12-09 06:00 am | Interim 2022 Earnings Call |
2021-12-06 02:00 am | Interim 2022 Earnings Release |
2021-09-24 06:00 am | Annual General Meeting |
2021-08-09 | FY 2021 Earnings Release |
Annual results
Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 2,18 | 3,90 3,80 2.5% | 0,00 | 0,00 | 2,90 2,85 1.79% | 1,15 |
EBITDA Million GBP | Released Forecast Spread | -1,10 | -0,44 -0,45 2.23% | 0,00 | 0,00 | -2,49 -2,35 -5.61% | -1,47 |
EBIT Million GBP | Released Forecast Spread | 0,00 | -1,06 -1,05 -0.86% | 0,00 | 0,00 | -2,86 -2,75 -4.08% | -1,72 |
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 0,00 | -1,07 -1,05 -2.58% | 0,00 | 0,00 | -2,86 -2,76 -3.59% | -1,74 |
Net income Million GBP | Released Forecast Spread | 0,00 | -0,70 -0,87 19.52% | -2,90 | -1,20 | -2,60 -2,46 -5.57% | -1,59 |
EPS GBP | Released Forecast Spread | -0,06 | -0,03 -0,04 17.95% | -0,11 | -0,05 | -0,10 -0,10 -5.26% | -0,03 |
Announcement Date | 02/07/19 | 19/08/20 | 10/08/21 | 23/08/22 | 29/09/23 | - |
Quarterly results
Fiscal Period | March | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 1,04 0,99 5.17% | 0,54 0,54 0% | 0,61 | |
EBITDA Million GBP | Released Forecast Spread | -1,48 -1,35 -9.81% | -1,23 -0,82 -49.94% | -0,24 | |
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -1,60 -1,50 -6.47% | -1,42 -0,95 -49.63% | ||
Net income Million GBP | Released Forecast Spread | -1,12 | |||
EPS GBP | Released Forecast Spread | -0,04 | |||
Announcement Date | 05/12/22 | 29/09/23 | 04/12/23 | - |
Past sector events for Fusion Antibodies plc
2024-05-09 | HUMACYTE, INC.: Q1 2024 Earnings Release |
2024-05-09 | NOVAVAX, INC.: Q1 2024 Earnings Release |
2024-05-09 | TAKARA BIO INC.: Q4 2023 Earnings Release |
2024-05-09 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-09 04:05 pm | BIOHAVEN LTD.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | OMNIAB, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 08:00 am | CG ONCOLOGY, INC.: Q1 2024 Earnings Release |
2024-05-09 08:00 am | DISC MEDICINE, INC.: Q1 2024 Earnings Release |
2024-05-09 08:00 am | VERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FAB Stock
- Calendar Fusion Antibodies plc